BioCentury
ARTICLE | Company News

Takeda mulls Shire takeover

March 30, 2018 5:45 PM UTC

Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) said it is considering a takeout of Shire plc (LSE:SHP; NASDAQ:SHPG), a move the pharma believes would strengthen its core pipeline areas of focus while adding Shire's expertise in rare diseases.

On March 28, Shire added 430p (14%) to 3,500p in London and climbed $15.66 (12%) to $144.53 on NASDAQ. Based on the 910 million shares in Shire's most recent 10-K, the NASDAQ move added about $4.8 billion to its market cap to close at $43.8 billion. Takeda's market cap is about ¥4.4 trillion ($41.6 billion)...